Morgan Stanley Care Dx, Inc. Transaction History

Morgan Stanley

$1.35 Trillion
Q3 2024

A detailed history of Morgan Stanley transactions in Care Dx, Inc. stock. As of the latest transaction made, Morgan Stanley holds 761,598 shares of CDNA stock, worth $18.7 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

761,598

Previous 630,902 20.72%

Holding current value

$18.7 Million

Previous $9.8 Million 142.7%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$14.41 - $33.99 $1.88 Million - $4.44 Million	130,696 Added 20.72%	761,598 $23.8 Million
Q2 2024 Oct 17, 2024	SELL	$7.56 - $16.15 $2.28 Million - $4.87 Million	-301,715 Reduced 32.35%	630,902 $9.8 Million
Q2 2024 Aug 14, 2024	SELL	$7.56 - $16.15 $2.28 Million - $4.87 Million	-301,715 Reduced 32.35%	630,902 $9.8 Million
Q1 2024 Oct 17, 2024	BUY	$7.96 - $12.37 $2.4 Million - $3.73 Million	301,715 Added 47.82%	932,617 $9.88 Million
Q1 2024 Aug 16, 2024	SELL	$7.96 - $12.37 $5.14 Million - $7.99 Million	-645,611 Reduced 40.91%	932,617 $9.88 Million
Q1 2024 May 15, 2024	SELL	$7.96 - $12.37 $5.14 Million - $7.99 Million	-645,611 Reduced 40.91%	932,617 $9.88 Million
Q4 2023 Aug 16, 2024	BUY	$4.9 - $12.86 $4.64 Million - $12.2 Million	947,326 Added 150.15%	1,578,228 $18.9 Million
Q4 2023 Feb 13, 2024	BUY	$4.9 - $12.86 $4.4 Million - $11.5 Million	897,839 Added 131.96%	1,578,228 $18.9 Million
Q3 2023 Nov 15, 2023	SELL	$7.0 - $11.26 $2.22 Million - $3.57 Million	-317,033 Reduced 31.79%	680,389 $4.76 Million
Q2 2023 Aug 14, 2023	SELL	$7.61 - $9.46 $865,074 - $1.08 Million	-113,676 Reduced 10.23%	997,422 $8.48 Million
Q1 2023 May 15, 2023	BUY	$8.83 - $17.61 $6.27 Million - $12.5 Million	710,386 Added 177.28%	1,111,098 $10.2 Million
Q4 2022 Feb 14, 2023	BUY	$10.88 - $20.05 $1.96 Million - $3.61 Million	179,949 Added 81.51%	400,712 $4.57 Million
Q3 2022 Nov 14, 2022	SELL	$16.06 - $26.39 $3.47 Million - $5.71 Million	-216,315 Reduced 49.49%	220,763 $3.76 Million
Q2 2022 Oct 27, 2022	SELL	$20.49 - $39.72 $10.1 Million - $19.6 Million	-493,686 Reduced 53.04%	437,078 $9.39 Million
Q2 2022 Aug 15, 2022	SELL	$20.49 - $39.72 $10.1 Million - $19.6 Million	-493,686 Reduced 53.04%	437,078 $9.39 Million
Q1 2022 Oct 27, 2022	BUY	$28.19 - $46.6 $13.9 Million - $23 Million	493,686 Added 112.95%	930,764 $34.4 Million
Q1 2022 May 13, 2022	BUY	$28.19 - $46.6 $9.3 Million - $15.4 Million	329,981 Added 54.93%	930,764 $34.4 Million
Q4 2021 Feb 14, 2022	SELL	$41.2 - $73.6 $10.3 Million - $18.4 Million	-249,501 Reduced 29.34%	600,783 $27.3 Million
Q3 2021 Nov 15, 2021	BUY	$59.15 - $91.99 $50.3 Million - $78.2 Million	850,284 New	850,284 $53.9 Million

Others Institutions Holding CDNA

# of Institutions

219

Shares Held

51.1M

Call Options Held

97.3K

Put Options Held

43.3K

View Full List

About CareDx, Inc.

Ticker CDNA
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 53,458,100
Market Cap $1.31B
Description
CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for...

More about CDNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Account